Abstract:Key PointsAutophagy is an intracellular protein degradation pathway in which substrates to be degraded are surrounded by a double membrane and trafficked to lysosomes. Aggregate-prone proteins involved in neurodegenerative diseases are substrates for degradation by this pathway.Autophagic dysfunction is increasingly being associated with the pathogenesis of neurodegenerative diseases. A recent and direct example is that mutations in the autophagy gene encoding WIPI4 (WDR45) cause the disease β-propeller protein-associated neurodegeneration (BPAN).Genetic variants associated with neurodegenerative diseases have been identified that affect many aspects of the autophagic pathway, including control of initiation (via Beclin 1 interactions), sequestration of substrates into autophagosomes, trafficking of autophagosomes to lysosomes and the degradative capacity of lysosomes.Although many perturbations in autophagy have been identified, it remains largely unclear how this contributes to disease pathogenesis and progression.Induction of autophagy can be protective in models of neurodegenerative diseases. Thus, understanding how autophagy is affected in these diseases is vital to facilitate the successful development of novel therapeutics that target the autophagy pathway.

Compromised autophagy and neurodegenerative diseases